Hims & Hers co-founder and CEO Andrew Dudum joins 'Squawk Box' to discuss how the company is integrating AI tools, why it's ...
Hosted on MSN
Hims & Hers adds Lilly GLP-1 treatments to lineup – CEO compares it to Netflix’s early days
・Hims & Hers CEO Andrew Dudum noted that, like Netflix gave users the choice of what they wanted most, Hims & Hers is similarly offering GLP-1 treatments on its platform. ・The telehealth platform now ...
・Dudum said the system could potentially combine information from at-home blood tests, connected scales, wearable devices and glucose monitors. ・Speaking on the FTC lawsuit, Dudum said the regulator ...
Hims & Hers CEO Andrew Dudum spoke to CNBC about the FTC's lawsuit against the company, compounded GLP-1 drugs and AI.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results